Cotinga Pharmaceuticals Inc

(COTQF)

By |
Cotinga Pharmaceuticals Inc

Profile

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

Contact Information

Website: www.cotingapharma.com
Email: ir@cotingapharma.com
Main Phone: +1 519 858-5157
Address: 82 Richmond Street East
Address 2: The Canadian Venture Building
State: ON
City / Town: Toronto
Country: CA
Postal Code: M5C1P1

Issuer Information

Exchange: OTO
CEO: Alison Silva
Employees: 6
Issuer Type: CS - Common Stock
Sector/Industry: Cyclical
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Cotinga Pharmaceuticals Inc

Profile

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

Contact Information

Website: www.cotingapharma.com
Email: ir@cotingapharma.com
Main Phone: +1 519 858-5157
Address: 82 Richmond Street East
Address 2: The Canadian Venture Building
State: ON
City / Town: Toronto
Country: CA
Postal Code: M5C1P1

Issuer Information

Exchange: OTO
CEO: Alison Silva
Employees: 6
Issuer Type: CS - Common Stock
Sector/Industry: Cyclical
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 0.01 $ 0. (0.00%)
Last Price 0.01 Change $ 0. Change % 0.00 Tick N/A
Bid 0.0135 Bid Size 10,000.00 Ask 1.00 Ask Size 200.00
Open N/A High N/A Low N/A Prev Close 0.01
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap 219,864 Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 16,686,968.00 EPS (TTM) N/A PE Ratio N/A Exchange OTCPK
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 3.65 3.65 3.65 3.65
Low Target Price Estimate 3.65 3.65 3.65 3.65
Mean Target Price Estimate 3.65 3.65 3.65 3.65
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 02/01/18 02/01/18 02/01/18 02/01/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago